SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-025727
Filing Date
2020-11-16
Accepted
2020-11-16 18:26:05
Documents
2
Period of Report
2020-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2957
2 EXHIBIT 24 brhc10017052_ex24.htm EX-24 4780
  Complete submission text file 0001140361-20-025727.txt   9344
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Zaremba Rabourn Amy (Reporting) CIK: 0001832343 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 201318791